However, the precise mechanisms by which AARS2 deficiency contributes to the development of cardiomyopathy in patients are not fully understood, and the potential of AARS2 as a therapeutic target for heart-related diseases remains to be explored. This evidence concerns the gene AARS2 and cardiomyopathy.